| Line item | 2026-01-31 FY | 2025-01-31 FY | 2024-01-31 FY | 2023-01-31 FY | 2022-01-31 FY | 2021-01-31 FY |
|---|---|---|---|---|---|---|
| Revenue | – | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | $1.09M | $1.70M | $1.54M | $836.07K | $517.76K | $594.89K |
| R&D | – | – | – | – | – | – |
| SG&A | $484.72K | $789.63K | $272.61K | $405.84K | $84.70K | $72.93K |
| Operating Income | -$1.09M | -$1.70M | -$1.54M | -$836.07K | -$517.76K | -$594.89K |
| Interest Expense | – | – | $213.02K | $245.16K | $147.20K | $185.64K |
| Tax Expense | – | – | – | – | – | – |
| Net Income | -$1.24M | $2.12M | -$4.08M | $565.60K | -$438.68K | -$749.75K |
| EPS (basic) | -0.0200 | 0.0400 | -0.1300 | 0.0400 | -0.0400 | -0.0800 |
| EPS (diluted) | -0.0200 | 0.0300 | -0.1300 | 0.0400 | -0.0400 | – |
| Shares (diluted) | $71.30M | $62.63M | $31.01M | $15.92M | $10.65M | – |